Mounjaro KwikPen

Mounjaro KwikPen is a prescription prefilled, multi-dose injection pen designed for the subcutaneous administration of tirzepatide in adults with type 2 diabetes and for chronic weight management where approved. It delivers accurate once-weekly dosing through the convenient KwikPen delivery system. The ergonomic pen enhances ease of use and supports long-term treatment adherence.

BUY NOW

Category

Mounjaro KwikPen contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps improve glycemic control by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The multi-dose KwikPen is engineered to provide precise once-weekly dosing with minimal preparation, ensuring reliable dose delivery and improved patient convenience. Manufactured under stringent pharmaceutical quality standards, each pen is supplied sterile for single-patient use. Mounjaro should be administered only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro KwikPen
Active Ingredient Tirzepatide
Dosage Form Prefilled Multi-Dose KwikPen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerated at 2°C–8°C before first use

Product Also Known As

Mounjaro KwikPen, Mounjaro Tirzepatide KwikPen, Tirzepatide KwikPen, Tirzepatide Injection Pen, Mounjaro Multi-Dose Pen, Dual GIP GLP-1 KwikPen, Weekly Tirzepatide Pen